Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia. (Q46514154)
Jump to navigation
Jump to search
scientific article published on 7 June 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia. |
scientific article published on 7 June 2008 |
Statements
Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia (English)
Haralampos J Milionis
Konstantinos G Lagos
Alexandros D Tselepis